Drugmakers are racing to develop treatments and vaccines that will help combat the coronavirus pandemic.
While that work progresses, biotech companies focused on finding treatments for conditions like Duchenne muscular dystrophy, cystic fibrosis, and Alzheimer's disease are carrying on their work with pivotal data or approvals expected in the next year. Analysts at UBS noted that they're optimistic about 2021, given how the biotech market performed in 2019 and so far in 2020. With that in mind, UBS analysts on Tuesday initiated coverage on nine biotech companies, four of which received buy ratings. Of those four, UBS anticipates two could soar more than 50%. UBS noted that in its initiation, it gravitated toward smaller companies. Here are the four biotech companies UBS initiated at a buy rating.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Business Insider webinar: How to invest ahead of 2020 election - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. I think there is a mistake coz you put Tom Lee's picture instead. You're welcome.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »
Goldman says investors will reward companies spending for growth, so these stocks could be winnersNew for subscribers: Goldman says investors will reward companies spending for growth, so these stocks could be winners Check out CNBCPro today. Pro Hi, I am Zain a full-time Graphic Designer. Expert in Logo Designing, Business Cards, and a lot more Designs. My priority is to satisfy my customers until their hundred percent satisfaction. Contact me if you have any questions. Thank you! Pro No time for this . Friday was the last oportunity for stimuli. A Big red coming. Today they Will speak líe and lie . Nothing change . A Big red to 3 november. All is ready Pro Goldman Sachs Asset Management has bot close to 50 Million shares of Draftkings in the last 2 weeks
La source: CNBC - 🏆 12. / 72 Lire la suite »
Investors flee risk, dumping stocks and buying bonds, as France nears national lockdown | Markets InsiderIf you looking for any Stationary Design then I am requesting you to please visit here good luck BITCOIN IS GOING NUTS!! It is up over $500 to $13.7k and it isn't suppose to slow down till 20k!!!! SHES A PEACH 🍑!!
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »
How a US Navy sailor used military perks to buy investment property - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Fidelity Looking for Awesome Logo, Brochure, Flyer, Brand Identify, Business Card, Background Remover?Contact
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »
Energy stocks plummet amid oil sell-off driven by threats of boosted production - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »